智能zwitterionic生物降解水凝用于持续的递送:应用于神经治疗性NX210c的应用
Elise Rosson1, Eloise Thomas2, Jacqueline Sidi-Boumedine3
1Axoltis Pharma, 60 Avenue Rockfeller 69008, Lyon, France; Universite Claude Bernard Lyon 1, CNRS UMR5007, LAGEPP, 43 boulevard du 11 novembre 1918, Bâtiment CPE, 69622 Villeurbanne Cedex, France; Universite Claude Bernard Lyon 1, CNRS UMR5306, ILM, 2 rue Victor Grignard, 69100 Villeurbanne, France.
Biomaterials advances
|August 5, 2025
概括
一种新型的基托桑水凝能够持续地皮下释放神经保护性NX210c,克服短半衰期的限制,改善神经疾病的治疗. 这种对患者友好的平台提供了长时间的治疗效果.
科学领域:
- 生物材料科学 生物材料科学
- 神经科学是一个神经科学.
- 药物输送系统 药物输送系统
背景情况:
- 像NX210c这样的治疗性具有神经保护潜力,但体内半衰期短,需要频繁的静脉注射.
- 目前的交付方法限制了患者的遵从性和神经疾病治疗的治疗结果.
研究的目的:
- 开发和评估一种可注射,可生物降解的水凝,用于持续地皮下输送神经保护性NX210c.
- 为了克服NX210c的药理动力学限制,并建立一种患者友好的静脉输液替代品.
主要方法:
- 在临床前开发了一种基于奇托桑的水凝,与DOTAGA功能化,用于持续释放NX210c.
- 在体外查可注射性,凝性,负荷和释放动力学.
- 在动物体内验证生物相容性,生物降解性和药物动力学概况.
主要成果:
- 水凝在动物身上证明了 in situ 的形成,可注射性,生物相容性和生物降解性.
- 皮下水凝给药维持了NX210c水平1015天,与静脉注射或自由皮下给药相比,AUC显著增加.
- 静脉注射NX210c在1小时内清除,而自由皮下注射持续了3小时.
结论:
- 开发的酸盐水凝是一种有前途的,临床可转换的平台,用于持续地皮下输送治疗性.
- 这种方法显著提高了的生物可用性和作用持续时间,为神经治疗提供了一个患者友好的替代方案.
- 需要进一步的研究来评估通过这种水凝系统输送的NX210c的治疗疗效.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


